Industry: Pharmaceuticals, Biotechnology
Targa Therapeutics Corporation is a biotechnology company based in San Diego, California and Houston, Texas. Targa was founded in October, 2002 with the goal of commercializing Targa Therapeutic Payloads, molecules that can be conjugated or fused to antibodies or other tumor targeting molecules to improve their potency/toxicity ratio (therapeutic index). Targa Therapeutic Payloads were developed by Michael G. Rosenblum, Ph.D., Head of the Section of Immunopharmacology and Targeted Therapy at The University of Texas M. D. Anderson Cancer Center in Houston, TX, one of the world’s leading cancer centers. Targa Therapeutic Payloads represent a major breakthrough in pharmaceutical ( www.targatherapeutics.com )
Targa Therapeutics Corporation
11585 Sorrento Valley Road Suite 108
San Diego, California 92121
USA
Tel: (858) 794-8000
Fax: (858) 794-8229